Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
Journal of Alzheimer s Disease2021Vol. 81(2), pp. 629–640
Citations Over TimeTop 10% of 2021 papers
Gustaf Boström, Eva Freyhult, Johan Virhammar, Daniel Alcolea, Hayrettin Tumani, Markus Otto, RoseMarie Brundin, Lena Kilander, Malin Löwenmark, Vilmantas Giedraitis, Alberto Lleó, Christine A. F. Von Arnim, Kim Kultima, Martin Ingelsson
Abstract
In this cross-sectional multi-center study, we found distinct patterns of CSF inflammatory marker levels in FTD and in both early and established AD, suggesting differing neuroinflammatory processes in the two disorders.
Related Papers
- → Role of Neuroinflammation in the Trajectory of Alzheimer’s Disease and in vivo Quantification Using PET(2018)61 cited
- → "Lipopolysaccharide-induced animal models for neuroinflammation – An overview."(2023)57 cited
- → Insights into the advances in therapeutic drugs for neuroinflammation-related diseases(2023)7 cited
- → Neuroinflammation and oxidative injury in developmental neurotoxicity(2011)13 cited
- → Characterisation of ReNcells CX and VM stimulated with interleukin-1β and lipopolysaccharide(2022)4 cited